Skip to content
ChickenStockChickenStock
ResearchHUM
Humana logo

Humana (HUM) stock

NYSE

$450+1.42%(+6.30)

As of the Nov 13, 2026 close (U.S. Eastern)

Events and reference metrics · 1

Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.

Price date for the multiples · Nov 13, 2026 · Financial period · Trailing twelve months

P/E and P/S use the latest four quarters where available · P/B uses the latest equity · Computed in-house by ChickenStock

P/E

43.34x

P/B

2.87x

P/S

0.35x

Latest earnings

SEC filings

Jul–Sep 2026(FY2026 Q3)

Revenue increased 26.1% from the same period a year earlier.

Key reported figures come first. Select one to see the same quarter across three years.

See the same quarter across three years →

Filed Nov 6, 2026 · 10-Q · SEC EDGAR

Reported results are from SEC EDGAR filings. Reference information only, not investment advice.

Insider transactions

Recent Form 4 filings grouped by person, date and transaction type.

7 SEC filings
  • Frederick Wayne A.I.Director · Nov 10, 2026Open-market sale440 shares · $194K
    Avg. price $440.5750 shares held after
  • Dintenfass DavidPresident, Enterprise Growth · Nov 10, 2026Gift230 shares · $0
    Avg. price $025,177 shares held after
  • Ventura Joseph CChief Legal Officer · Nov 9, 2026Open-market sale5,495 shares · $2.4M
    Avg. price $433.851421,910 shares held after
  • Ventura Joseph CChief Legal Officer · Nov 9, 2026Gift437 shares · $0
    Avg. price $021,473 shares held after
  • Nundy ShantanuChief Medical Officer · Sep 1, 2026Grant or award2,549 shares · $0
    Avg. price $02,549 shares held after
  • Smith Paul JohnDirector · Aug 1, 2026Grant or award544 shares · $0
    Avg. price $0544 shares held after
  • Crawford Frederick JohnDirector · Aug 1, 2026Grant or award544 shares · $0
    Avg. price $0544 shares held after

Only transactions reported on SEC Form 4 are shown. A sale may follow a pre-arranged 10b5-1 plan, and items such as option exercises or shares withheld for taxes are not open-market trades.

Recent SEC filings

40 filings

Filings submitted to the U.S. Securities and Exchange Commission (EDGAR). Dates are SEC filing dates (U.S. Eastern). Form and item names are the official SEC titles. The Earnings and Risk tags come directly from form types and item codes; they are not written by AI. Insider ownership reports (Forms 3, 4 and 5) are excluded.

Company overview

Expand ▾

Humana (HUM) stock information

NYSE

Humana (HUM) is listed on NYSE. Its market capitalization is about $54B. On trailing-twelve-month earnings the P/E ratio is 43.34, and the P/B ratio is 2.87. Return on equity is 6.6%. These figures are computed in-house from official filings and are reference information only.

Humana — frequently asked questions

What is the P/E ratio of Humana (HUM)?
On a trailing-twelve-month basis, HUM trades at a P/E ratio of 43.34. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
What is the market capitalization of Humana?
HUM has a market capitalization of about $54B. The figure moves with the share price and is refreshed each trading day.
Does Humana pay a dividend?
HUM has a dividend yield of about 0.79%, based on disclosed payment history. Dividend policy can change; this is reference information only.
Is this page investment advice?
No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.

All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.